Experts warn about the overuse of the last-resort antibiotic ceftazidime-avibactam, leading to resistance. They urge stricter regulations to prevent misuse and preserve its efficacy. The concern is amplified by the upcoming release of two more powerful antibiotics; proactive measures are vital.
